Drug association Efpia ‘regrets’ Lundbeck judgment from EU General Court
MLex Summary: The pharmaceutical organization Efpia has said it “regrets” EU judges’ ruling to classify Lundbeck’s patent-settlement agreements as restrictive “by object.” The General Court sided with European Commission, which found that...To view the full article, register now.
Already a subscriber? Click here to view full article